Hbk Sorce Advisory LLC Pfizer Inc Transaction History

Hbk Sorce Advisory LLC

$2.56 Billion
Q3 2024

A detailed history of Hbk Sorce Advisory LLC transactions in Pfizer Inc stock. As of the latest transaction made, Hbk Sorce Advisory LLC holds 139,892 shares of PFE stock, worth $3.72 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

139,892

Previous 135,558 3.2%

Holding current value

$3.72 Million

Previous $3.79 Million 6.75%

% of portfolio

0.16%

Previous 0.14%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$27.7 - $31.39 $120,051 - $136,044	4,334 Added 3.2%	139,892 $4.05 Million
Q2 2024 Aug 08, 2024	BUY	$25.26 - $29.6 $227,794 - $266,932	9,018 Added 7.13%	135,558 $3.79 Million
Q1 2024 May 09, 2024	BUY	$25.89 - $29.73 $164,841 - $189,290	6,367 Added 5.3%	126,540 $3.51 Million
Q4 2023 Jan 25, 2024	SELL	$26.13 - $33.94 $250,534 - $325,416	-9,588 Reduced 7.39%	120,173 $3.46 Million
Q3 2023 Nov 06, 2023	BUY	$32.09 - $37.51 $92,098 - $107,653	2,870 Added 2.26%	129,761 $4.3 Million
Q2 2023 Aug 04, 2023	SELL	$36.12 - $41.79 $5.15 Million - $5.96 Million	-142,687 Reduced 52.93%	126,891 $4.65 Million
Q1 2023 Aug 15, 2023	SELL	$39.39 - $51.28 $632,682 - $823,659	-16,062 Reduced 12.66%	110,829 $4.52 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $69,483 - $90,457	-1,764 Reduced 0.65%	269,578 $16.6 Million
Q4 2022 Feb 09, 2023	BUY	$41.75 - $54.5 $6.33 Million - $8.27 Million	151,706 Added 126.81%	271,342 $13.9 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $1.78 Million - $2.17 Million	40,713 Added 51.59%	119,636 $5.24 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $2.16 Million - $2.56 Million	-46,468 Reduced 37.06%	78,923 $4.14 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $564,189 - $699,101	-12,332 Reduced 8.95%	125,391 $6.49 Million
Q4 2021 Feb 15, 2022	SELL	$41.32 - $61.25 $35,576 - $52,736	-861 Reduced 0.62%	137,723 $8.13 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $648,292 - $832,787	-16,517 Reduced 10.65%	138,584 $5.96 Million
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $883,242 - $1 Million	24,596 Added 18.85%	155,101 $6.07 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $71,601 - $80,752	2,138 Added 1.67%	130,505 $4.73 Million
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $353,777 - $449,859	10,570 Added 8.97%	128,367 $4.73 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $120,967 - $141,922	3,810 Added 3.34%	117,797 $4.32 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $193,099 - $234,257	6,411 Added 5.96%	113,987 $3.73 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $152,043 - $217,237	-5,625 Reduced 4.97%	107,576 $3.51 Million
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $298,781 - $339,079	9,076 Added 8.72%	113,201 $4.44 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $81,289 - $105,409	2,502 Added 2.46%	104,125 $3.74 Million
Q2 2019 Aug 15, 2019	BUY	$36.98 - $41.52 $1 Million - $1.13 Million	27,166 Added 36.49%	101,623 $4.4 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $828,241 - $929,923	-22,397 Reduced 23.12%	74,457 $2.62 Million
Q1 2019 May 13, 2019	BUY	$37.5 - $41.2 $26,512 - $29,128	707 Added 0.74%	96,854 $4.11 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $62,744 - $71,535	1,631 Added 1.73%	96,147 $4.2 Million
Q3 2018 Nov 15, 2018	SELL	$34.47 - $41.81 $49,154 - $59,621	-1,426 Reduced 1.49%	94,516 $4.17 Million
Q2 2018 Aug 10, 2018	SELL	$32.98 - $35.16 $132,612 - $141,378	-4,021 Reduced 4.02%	95,942 $0
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $242,643 - $281,500	7,604 Added 8.23%	99,963 $3.55 Million
Q4 2017 Feb 15, 2018	BUY	$33.26 - $35.29 $728,759 - $773,239	21,911 Added 31.1%	92,359 $3.35 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $2.18 Million - $2.41 Million	70,448	70,448 $2.52 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hbk Sorce Advisory LLC with notifications on news.

Account

Hbk Sorce Advisory LLC Pfizer Inc Transaction History